XECHEM/SHANGHAI FUDAN TO DEVELOP NEW PACLITAXEL ANALOGS.Xechem International, Inc. (OTCBB OTCBB See OTC Bulletin Board (OTCBB). :ZKEM), New Brunswick New Brunswick, province, Canada New Brunswick, province (2001 pop. 729,498), 28,345 sq mi (73,433 sq km), including 519 sq mi (1,345 sq km) of water surface, E Canada. , N.J., and Xechem Pharmaceutical China Ltd. have signed a cooperation agreement with Shanghai Fudan Taxusal New Technology Co., Ltd. located within the Science and Technology Industry Park of Shanghai Universities. This agreement's objective is the co-development of new paclitaxel paclitaxel /pac·li·tax·el/ (pak?li-tak´sel) an antineoplastic that promotes and stabilizes polymerization of microtubules, isolated from the Pacific yew tree (Taxus brevifolia); soluble analogs and other natural products isolated from Chinese traditional medicines Chinese traditional medicine an ancient health care system based on the concept of vital energy (Qi) and the opposing forces of yin (negative energy) and yang (positive energy). It incorporates herbal medicine, exercises, meditation and acupuncture. . According to Dr. Ramesh Pandey, Xechem's president & CEO (1) (Chief Executive Officer) The highest individual in command of an organization. Typically the president of the company, the CEO reports to the Chairman of the Board. , "We are excited with this alliance which is going to be very beneficial to all the parties. Shanghai Fudan Taxusal New Technology Co. is involved in the isolation and purification of paclitaxel and preparation of the next generation of paclitaxel. They have the necessary alliances and contracts with the Taxus yunancesis growers for the raw material and with Fudan University, one of the three top universities in China. The President of the Shanghai Company, Professor Wei Runbai, has the foresight, vision and resources to bring these products to the market." On signing the agreement, Professor Wei Runbai said, "Xechem has contributed significantly to the development of paclitaxel, its analogs and a number of other natural products. We take it seriously to cooperate with Xechem. This alliance will speed up the research and development of Chinese Herbal Medicines Chinese herbal medicine see herbal medicine. and promote pure-compound products into international markets. It will play an important role to introduce the technologies and new natural products." C.K. Wong, president of Xechem Pharmaceutical China, Ltd. stated, "This cooperation will accelerate the ongoing studies between Xechem International and Xechem Pharmaceutical China, Ltd.." Xechem International of New Brunswick, NJ, with subsidiary companies in USA, India and joint venture partners in both Hong Kong and Peoples Republic of China, is a biopharmaceutical company of which Xechem, Inc. (a U.S. subsidiary) is engaged in the research, development and production of generic and proprietary pharmaceuticals from natural sources, specializing in the development of niche, generic, difficult to replicate anticancer, antiviral antiviral /an·ti·vi·ral/ (-vi´ral) destroying viruses or suppressing their replication, or an agent that so acts. an·ti·vi·ral adj. (including Human Immuno-deficiency Virus, HIV HIV (Human Immunodeficiency Virus), either of two closely related retroviruses that invade T-helper lymphocytes and are responsible for AIDS. There are two types of HIV: HIV-1 and HIV-2. HIV-1 is responsible for the vast majority of AIDS in the United States. ) and antifungal compounds. The company also screens extracts and pure compounds from China and India for their therapeutic use. XetaPharm (another U.S. subsidiary) develops quality controlled nutritional products as GinkgoOnce(R), GinsengOnce(R), GarlicOnce(R), Gugulon(TM), and Co-Enzyme Q-10 and numerous products, which are under development. For more information, visit http://www.xetapharm.com or call 732/247-3300. |
|
||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion